Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024Regulatory Challenges in the CIS and Russia - TOPRA In CEE Webinar
TOPRA CEE Steering Committee announces the Webinar “Regulatory Challenges in the CIS and Russia” which will be organized on 14th December 2023 (09:00-11:00 GMT / 10:00-12:00 CET). TOPRA is the leading global organization for all professionals in healthcare regulatory affairs.
The pharmaceutical market in the CIS is one of the most dynamic and complex regions in the regulatory area. Due to global geopolitical changes, the pharmaceutical market in the CIS has also experienced significant regulatory challenges.
This webinar will cover the latest updates, requirements, and trends in the EAEU market (Belarus, Kazakhstan, Armenia, Kyrgyzstan, Russia), as well as in the markets of Ukraine, Moldova, Azerbaijan, Georgia, Mongolia, and Uzbekistan, as large and fast-growing markets in Central Asia. During the webinar, Q&A sessions will be organized with the participation of the speaker and regional top-level experts.
The webinar speaker is Dr. Polina Dombure MD, PhD, Member of the TOPRA CEE Steering Committee, CEO Inpharmatis Group. Dr. Polina Dombure has over 20 years of experience in the Life Sciences Industry and is a regionally experienced expert in the CIS and EU markets, with deep expertise in all types of products in Regulatory Affairs, Pharmacovigilance, and Quality, continuously growing and expanding knowledge of the region into successful projects.
The webinar will be useful for Regulatory Affairs Managers and Specialists from HQ and clusters responsible for CIS, EAEU, and Russian markets.
Stay up-to-date with the latest changes and developments in regulatory frameworks of the CIS countries.
To register for the webinar, please visit the Webinar page on TOPRA website - LINK TO REGISTRATION PAGE.
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024